课题基金 / 基金详情

HOD2: Instrumental Variable approaches for estimating heterogeneity of treatment effects to inform personalisation using electronic health records

HOD2: Instrumental Variable approaches for estimating heterogeneity of treatment effects to inform personalisation using electronic health records
HOD2:用于估计治疗效果异质性的工具变量方法,以使用电子健康记录为个性化提供信息
批准号:
MR/T025212/1
负责人:
Richard Grieve
金额:
$64.68万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

Richard Grieve的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Personalised medicine aims to provide the right treatment for the right patient at the right time. The evidence to inform personalised medicine can come from patient's electronic health records. However, there are several problems with using these data to compare outcomes for groups of patients who receive alternative treatments. First, the patients in the two groups may differ according to characteristics that are not measured (for example, the patient's frailty). Second, the extent to which an intervention leads to an improvement in the patients' outcome (or harm) may differ according to these unmeasured characteristics. Third, it is often unknown which patient groups benefit from which interventions. Methods for addressing these three problems are currently unavailable. This project will develop new methods that resolve these problems and provide more accurate estimates of the effectiveness and harms of new treatments that apply to individual patients. In particular, we will develop new methods that make more realistic assumptions. Instead of assuming that we know which patient groups benefit from which treatment, we will develop approaches that can learn from the data about which subgroups benefit from which treatment. We will examine how well these new methods work in practice by testing them as part of new studies. One of these studies will examine which patients benefit from emergency surgery for common acute conditions (e.g. appendicitis), and uses data from 1.5 million hospital episodes. The other study considers which patients with type 2 Diabetes Mellitus benefit from new, more costly oral treatments, and uses prescription data from General Practice databases for 25,000 patients. Our new methods will enable us to provide more accurate, relevant evidence about which interventions work best for which patients with these two conditions. We will provide a general framework for these methods that can be applied across many different disease areas and countries. To help future studies, we will provide tutorials and guidance on using and adapting these methods in different contexts. We will run short courses and workshops to assist those designing, analysing and interpreting studies that use electronic health records to inform treatment decisions for individual patients.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/hec.4719
发表时间: 2023
期刊: Health economics
影响因子: 2.1
作者: [Moler-Zapata S]
通讯作者: Moler-Zapata S
DOI: 10.1177/0272989x221100717
发表时间: 2022-10
期刊: MEDICAL DECISION MAKING
影响因子: 3.6
作者: [Sadique, Zia, Grieve, Richard, Diaz-Ordaz, Karla, Mouncey, Paul, Lamontagne, Francois, O'Neill, Stephen]
通讯作者: O'Neill, Stephen
DOI: 10.1177/0272989x221100799
发表时间: 2022-11
期刊: MEDICAL DECISION MAKING
影响因子: 3.6
作者: [Moler-Zapata, Silvia, Grieve, Richard, Lugo-Palacios, David, Hutchings, A., Silverwood, R., Keele, Luke, Kircheis, Tommaso, Cromwell, David, Smart, Neil, Hinchliffe, Robert, O'Neill, Stephen]
通讯作者: O'Neill, Stephen
Improving analytical methods for reducing selection bias in health economic evaluation
DEVELOPING APPROPRIATE ANALYTICAL METHODS FOR COST-EFFECTIVENESS ANALYSES THAT USE CLUSTER RANDOMISED TRIALS
海外基金